Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.

Completed · Not applicable

Conditions studied: Autosomal Dominant Hypophosphatemic Rickets

In brief

The purpose of the study is to gain a better understanding of the effect of iron on fibroblast growth factor 23 (FGF23) in the inherited disorder, autosomal dominant hypophosphatemic rickets (ADHR). ADHR is an inherited disorder in which the body makes too much FGF 23 and causes low blood phosphorus levels and bone problems such as rickets (bowed legs in children) or bone pain and weakness in adults. This study is to test whether or not giving iron helps correct the high FGF23 and there by correcting the phosphate problem.

Key facts

Study ID
NCT02233322
Run by
Indiana University
People needed
8
Starts
2014-08-01
Expected to finish
2019-11-12
Last updated by the study team
2019-11-14

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.